Loading stock data…
Kestra Medical Technologies (KMTS)
$21.06-0.51 (-2.36%)
After Hours$21.06+0.00 (+0.00%)· Last close Jul 24
Kestra Medical Technologies, Ltd.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Kestra Medical Technologies, Ltd. in the Healthcare sector is trading at $21.06 with a market capitalization of $1.1B. Wall Street consensus targets $30.00 (6 analysts), implying a +42.5% move over the next 12 months. The stock is currently 30% below its 52-week high of $30.00, remaining 10.5% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 16 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +42.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 16) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $24.55M↑ | $22.57M↑ | $19.37M↑ | $17.23M↑ | $15.09M |
| Gross Profit | $12.91M↑ | $11.42M↑ | $8.85M↑ | $7.63M↑ | $6.55M |
| Operating Income | -$34.77M↓ | -$31.75M↓ | -$28.88M↑ | -$48.21M↓ | -$20.60M |
| Net Income | -$34.17M↓ | -$32.78M↓ | -$25.83M↑ | -$52.05M↓ | -$21.51M |
Peer Comparison
JNJUNHPFE
Fundamentals
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitiv...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.14B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-50.29%
Volume
Today's trading volume
170,305
Recent News
Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...
Despite a significant net loss, Kestra Medical Technologies Ltd (KMTS) reports robust revenue growth and strategic advancements in sales territories and product innovation.
Kestra Medical Technologies Q4 Earnings Call Highlights
Kestra Medical Technologies (NASDAQ:KMTS) reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company’s ASSURE wearable cardioverter defibrillator system is being driven by new accounts, deeper penetratio
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
Kestra Medical Technologies, Ltd. (KMTS) delivered earnings and revenue surprises of -13.56% and +8.05%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Weakness
Kestra Medical Technologies (KMTS) has drawn investor attention after recent trading left the stock about 23% lower over the past month and roughly 28% lower over the past 3 months. See our latest analysis for Kestra Medical Technologies. With the share price at US$19.46, the stock has a 7 day share price return of 1.9%. However, the 30 day and year to date share price returns of about 23% and 20% declines point to fading short term momentum, despite a 1 year total shareholder return of...
Kestra Medical Technologies Q3 Earnings Call Highlights
Kestra Medical Technologies (NASDAQ:KMTS) reported what management described as a strong third quarter of fiscal 2026, highlighted by higher prescriptions, accelerating revenue growth, and continued gross margin expansion as the company scales its wearable cardioverter defibrillator (WCD) business a